Unknown

Dataset Information

0

Immunogenicity, Safety, and Anti-Viral Efficacy of a Subunit SARS-CoV-2 Vaccine Candidate in Captive Black-Footed Ferrets (Mustela nigripes) and Their Susceptibility to Viral Challenge.


ABSTRACT: A preliminary vaccination trial against the emergent pathogen, SARS-CoV-2, was completed in captive black-footed ferrets (Mustela nigripes; BFF) to assess safety, immunogenicity, and anti-viral efficacy. Vaccination and boosting of 15 BFF with purified SARS-CoV-2 S1 subunit protein produced a nearly 150-fold increase in mean antibody titers compared to pre-vaccination titers. Serum antibody responses were highest in young animals, but in all vaccinees, antibody response declined rapidly. Anti-viral activity from vaccinated and unvaccinated BFF was determined in vitro, as well as in vivo with a passive serum transfer study in mice. Transgenic mice that received BFF serum transfers and were subsequently challenged with SARS-CoV-2 had lung viral loads that negatively correlated (p < 0.05) with the BFF serum titer received. Lastly, an experimental challenge study in a small group of BFF was completed to test susceptibility to SARS-CoV-2. Despite viral replication and shedding in the upper respiratory tract for up to 7 days post-challenge, no clinical disease was observed in either vaccinated or naive animals. The lack of morbidity or mortality observed indicates SARS-CoV-2 is unlikely to affect wild BFF populations, but infected captive animals pose a potential risk, albeit low, for humans and other animals.

SUBMITTER: Leon AE 

PROVIDER: S-EPMC9612080 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Immunogenicity, Safety, and Anti-Viral Efficacy of a Subunit SARS-CoV-2 Vaccine Candidate in Captive Black-Footed Ferrets (<i>Mustela nigripes</i>) and Their Susceptibility to Viral Challenge.

Leon Ariel E AE   Garelle Della D   Hartwig Airn A   Falendysz Elizabeth A EA   Ip Hon S HS   Lankton Julia S JS   Tretten Tyler N TN   Spraker Terry R TR   Bowen Richard R   Rocke Tonie E TE  

Viruses 20221004 10


A preliminary vaccination trial against the emergent pathogen, SARS-CoV-2, was completed in captive black-footed ferrets (Mustela nigripes; BFF) to assess safety, immunogenicity, and anti-viral efficacy. Vaccination and boosting of 15 BFF with purified SARS-CoV-2 S1 subunit protein produced a nearly 150-fold increase in mean antibody titers compared to pre-vaccination titers. Serum antibody responses were highest in young animals, but in all vaccinees, antibody response declined rapidly. Anti-vi  ...[more]

Similar Datasets

| S-EPMC10891159 | biostudies-literature
| S-EPMC7584211 | biostudies-literature
| S-EPMC10848218 | biostudies-literature
| PRJNA254451 | ENA
| S-EPMC10963785 | biostudies-literature
| S-EPMC8742283 | biostudies-literature
| S-EPMC11825693 | biostudies-literature
2023-09-20 | PXD044152 | Pride
| S-EPMC5359545 | biostudies-literature
| PRJNA637759 | ENA